A new drug called ospemifene shows great promise in treating female dryness and dyspareunia in a recent study, and new hope for non-estrogen-based treatments is born among women who experience these painful problems.
A study of nearly 1,000 postmenopausal women showed that ospemifene, an estrogen-receptor modulator, significantly reduced female dryness and dyspareunia among participants. Women who struggle with VVA, vulvovaginal atrophy, have new hope for getting treated. In the United States, only estrogen-based cures have been approved to treat VVA. Many women shy away from estrogen hormone replacement therapies because they lead to increased risk of breast and other cancers.
Ospemifene, shorted to OSP, was given to the women in a 12-week, placebo-controlled study. The drug performed favorably in the phase III trials. Women who suffered with moderate to severe female dryness and/or moderate to severe dyspareunia saw improvement when they used the drug. Women in the study ranged from 40 to 80. Those who participated were encouraged to use vaginal lubricant whenever necessary to spot-treat female dryness.
Few negative reactions were observed in those who received the drug. Only 8% of women experienced urinary tract infection while taking the drug, 7% experienced hot flashes and 5% noticed vaginal discharge. No cases of death, breast cancer or myocardial infarctions were discovered during the test.
Dyspareunia and female dryness
Female dryness is a common problem that many women experience during and after menopause. Your natural lubrication may naturally lessen over time as the estrogen levels in your body lower. Dryness may lead to dyspareunia, painful sexual intercourse.
Women who experience dryness and dyspareunia may believe they have decreased desire, and may avoid having sex altogether as a result of the pain and these feelings. But dryness doesn’t automatically translate into lack of lust, and sex is a healthy way to stay in touch with your body and remain close to a romantic partner.
Maintaining a healthy sex life prevents vaginal atrophy, which could keep you from enjoying sex in the future. As women age and estrogen levels decrease, the walls of the vagina may shrink. When atrophy occurs, the vagina is too small for sexual intercourse. Women who experience atrophy may need surgery to correct the problem. It is not difficult treat female dryness with vaginal lubricants that supplement your own natural moisture, but women do have hope that new, non-harmful drug therapies will be available to them in the future.
Learn more about staying sexually healthy in our free special report, Top 5 Treatments for Vaginal Dryness and Dyspareunia (Sexual Intercourse Pain).